Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents

REFERENCES

• Iosifescu DV, Babkier B, Fava M. Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Curr Psych Rep. 2004;6:193–201.
   Google Scholar
• el-Miedany YM, el-Rasheed AH. Is anxiety a more common disorder than depression in rheumatoid arthritis? Joint Bone Spine. 2002;69:300-6.
   Google Scholar
• Dickens C, Jackson J, Tomenson B, Hay E, Creed F. Association of depression and rheumatoid arthritis. Psychosomatics. 2003;44: 209–15.
   Google Scholar
• Frank RG, Beck NC, Parker JC, Kashani JH, Elliott TR, Haut AE. Depression in rheumatoid arthritis. J Rheumatol. 1988;15:920–5.
   PubMed Web of Science ®Google Scholar
• Japan Rheumatism Support Association. Rheumatism white paper/actual state of rheumatology patients. Tokyo: Japan Rheumatism Support Association; 2005. p. 73.
   Google Scholar
• Miwa Y, Yajima N, Shiozawa F, Yoda Y, Hanaoka R, Hanyuda M, et al. Relationship of between psychological factors and arthralgia in patients with rheumatoid arthritis. Mod Rheum. 2002;12:32–6.
   PubMedGoogle Scholar
• St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of Infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 2004;50:3432–43.
   PubMed Web of Science ®Google Scholar
• Miwa Y, Hosaka M, Matsushima D, Wakabayashi Km Odai T, Matsunawa M et al. Compared to monotherapy with methotex-trate, inflixmab treatment is more powerful in improving depression in rheumatoid arthritis patients. Jpn J Psychosom Med. 2008;48:289–95.
   Google Scholar
• Miwa Y, Sato M, Takahashi R, Wakabayashi K, Odai T, Isozaki T, et al. Mechanism of improving depression state of rheumatoid arthritis patients by etanercept treatment. Clin Rheumatol. 2010;22:91–8.
   Google Scholar
• Kawai S, Hashimoto H, Kondo H, Murayama T, Kiuchi T, Abe T. Comparion of tacrolimus and mizoribine in a randomized, dou-ble-blind controlled study in patients with rheumatoid arthritis. J Rheumatol. 2006;33:2153–61.
   PubMed Web of Science ®Google Scholar
• Aramaki T, Kawakami A, Iwamoto N, Fujikawa K, Kawashiri SY, Tamai M, et al. Prediction of DA528-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables. Mod Rheumatol. 2009;19: 652–6.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Saito K, Tsujimura S, Nakayamada S, Yamaoka K, Sawamukai N et al. Tacrolimus, a calcineurin inhibitor, over-comes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis. J Rheumatol. 2010;37:512–20.
   PubMed Web of Science ®Google Scholar
• Yokota K, Akiyama Y, Asanuma Y, Miyoshi F, Sato K, Mimura T, et al. Efficacy of tacrolimus in infliximab-refractory progres-sive rheumatoid arthritis. Rheumatol Int. 2008;29:459–61.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Japan College of Rheumatology. Guidelines for use of TNF inhibitor treatment for rheumatoid arthritis. Tokyo: Japan College of Rheumatology; 2006.
   Google Scholar
• Zung WWK. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Kobayashi S. Guidance for using the Japanese self-rating depression scale. Kyoto: Sankyobo; 1983. pp. 3–15.
   Google Scholar
• Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, va Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
   Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breed-veld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000;343:1594–602.
   Google Scholar
• Hocaoglu C, Kural B, Aliyazicioglu R, Deger 0, Cengiz S. IL-1/3, IL-6, IL-8, IL-10, IFN-y, TNF-a and its relationship with lipid parameters in patients with major depression. Metab Brain Dis. 2012. (in press)
   Google Scholar
• Tsujimura S, Saito K, Nakayamada S, Nakano K, Tsukada J, Konno K, Tanaka Y. Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes. Genes Cells. 2004;9: 1265–73.
   Google Scholar
• Tsujimura S, Saito K, Nakayamada S, Nakano K, Tanaka Y. Clinical relevance of expression of P-glycoprotein on peripheral lymphocytes to steroid-resistance in systemic lupus erythe-matosus. Arthritis Rheum. 2005;52:1676–83.
   Google Scholar
• Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis. 2008;67:380–8.
   Google Scholar
• Piilgaad H, Witgen BM, Rasmussen P, Lauritzen M. Cyclosporin A, FK506, and NIM811 ameliorate prolonged CBF reduction and impaired neurovascular coupling after cortical spreading depression. J Cereb Blood Flow Metab. 2011;3:1588–98.
   Google Scholar